TY - JOUR
AU - N. Metrebian
AU - B. Carter
AU - D. Eide
AU - R. McDonald
AU - J. Neale
AU - S. Parkin
AU - T. Dascal
AU - C. Mackie
AU - E. Day
AU - J. Guterstam
AU - K. Horsburgh
AU - M. Kåberg
AU - M. Kelleher
AU - J. Smith
AU - H. Thiesen
AU - J. Strang
A1 - 
AD - National Addiction Centre, King's College London, London, UK.;Biostatistics and Health Informatics, King's College London, London, UK.;Norwegian Centre for Addiction Research, University of Oslo, Oslo, Norway.;Birmingham & Solihull Mental Health NHS Foundation Trust, Birmingham, UK.;Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet, & Stockholm Health Care Services, Stockholm County Council, Stockholm, Sweden.;Scottish Drugs Forum, Glasgow, Scotland, UK.;Stockholm Centre for Dependency Disorders, Stockholm, Sweden.;Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.;South London and Maudsley NHS Foundation Trust, London, UK.;Public Health Wales, Cardiff, Wales, UK.;Sundheds Team, City of Copenhagen, Denmark.;National Addiction Centre, King's College London, London, UK. John.strang@kcl.ac.uk.;South London and Maudsley NHS Foundation Trust, London, UK. John.strang@kcl.ac.uk.
AN - 37612698
BT - BMC Public Health
C5 - Opioids & Substance Use
CP - 1
DA - Aug 24
DO - 10.1186/s12889-023-16445-6
DP - NLM
ET - 20230824
IS - 1
JF - BMC Public Health
LA - eng
PY - 2023
SN - 1471-2458
SP - 1608
ST - A study protocol for a European, mixed methods, prospective, cohort study of the effectiveness of naloxone administration by community members, in reversing opioid overdose: NalPORS
T1 - A study protocol for a European, mixed methods, prospective, cohort study of the effectiveness of naloxone administration by community members, in reversing opioid overdose: NalPORS
T2 - BMC Public Health
TI - A study protocol for a European, mixed methods, prospective, cohort study of the effectiveness of naloxone administration by community members, in reversing opioid overdose: NalPORS
U1 - Opioids & Substance Use
U3 - 10.1186/s12889-023-16445-6
VL - 23
VO - 1471-2458
Y1 - 2023
ER -